Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
470.02
+104.01 (28.42%)
At close: May 12, 2025, 4:00 PM
469.45
-0.57 (-0.12%)
After-hours: May 12, 2025, 7:01 PM EDT
RGC Market Cap
RGC has a market cap or net worth of $6.12 billion as of May 12, 2025. Its market cap has increased by 13,523.77% in one year.
Market Cap
6.12B
Enterprise Value
6.11B
1-Year Change
13,523.77%
Ranking
Category
Stock Price
$470.02
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $6.12B, an increase of 4,992.68%. That is a compound annual growth rate of 180.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 4.76B | 7,309.11% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |